Profil
Richard W.
Wagner was the founder of X-Chem, Inc. (Massachusetts), founded in 2009, serving as Chief Executive Officer from 2009 to 2020.
Dr. Wagner is the founder of Bonito Biosciences, Inc., founded in 2019, serving as Chief Executive Officer & Director.
Dr. Wagner was the founder of Zebiai Therapeutics, Inc., founded in 2019, serving as Chief Executive Officer.
Dr. Wagner is also the founder of X Rx, Inc...
Dr. Wagner was an Independent Director at Ernexa Therapeutics, Inc. in 2023.
Dr. Wagner was Executive Vice President-Discovery Research at Praecis Pharmaceuticals, Inc. Dr. Wagner earned a doctorate from Brown University.
Dr. Wagner completed undergraduate studies at Trinity College (Connecticut).
Aktive Positionen von Richard Wagner
| Unternehmen | Position | Beginn |
|---|---|---|
Bonito Biosciences
Bonito Biosciences Packaged SoftwareTechnology Services Provides AI based drug target services | Gründer | - |
Ehemalige bekannte Positionen von Richard Wagner
| Unternehmen | Position | Ende |
|---|---|---|
| ERNEXA THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 08.08.2023 |
X-Chem, Inc. (Massachusetts)
X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services Provides DNA-encoded library-based drug discovery technology services | Vorstandsvorsitzender | 03.06.2020 |
X Rx, Inc.
X Rx, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule medicines in inflammation, fibrosis and oncology | Gründer | - |
Zebiai Therapeutics, Inc.
Zebiai Therapeutics, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets | Vorstandsvorsitzender | - |
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and therapies for the treatment of cancer | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Richard Wagner
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and therapies for the treatment of cancer | Health Technology |
X Rx, Inc.
X Rx, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule medicines in inflammation, fibrosis and oncology | Health Technology |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trinity College (Connecticut)
Trinity College (Connecticut) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
X-Chem, Inc. (Massachusetts)
X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services Provides DNA-encoded library-based drug discovery technology services | Technology Services |
Zebiai Therapeutics, Inc.
Zebiai Therapeutics, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets | Technology Services |
Eterna Therapeutics, Inc.
Eterna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer | Health Technology |
Bonito Biosciences
Bonito Biosciences Packaged SoftwareTechnology Services Provides AI based drug target services | Technology Services |
















